Key facts
- Notable investors include Hefei Innovation Technology Venture Capital, Hefei Hi-Tech VC, USTC Silicon Valley, Ningbo Pancheng Zhixin Investment.
- Status: Privately Held (backing).
- ·The complete investor list — 4 names
- ·Watchlist + deal alerts for Hanyin Life
- ·The full record, as it builds
Funding rounds
No funding rounds for Hanyin Life are on record yet — either the company hasn't raised institutional capital, or the raise hasn't surfaced in our sources.
About Hanyin Life
Manufacturer of early warning life science testing and diagnostic solutions aims to support proactive healthcare and disease prevention. The company's offerings feature rapid diagnostic assays, biosensor platforms, and customized health screening services, helping hospitals, clinics, and corporate health centers detect biomarkers early, monitor health status efficiently, and improve diagnostic accuracy, enabling scalable implementation of preventive medical infrastructure across clinical and enterprise settings.
- Sector
- Healthcare
- HQ
- Hangzhou, China
- Founded
- 2017
- Website
- hangenetics.com/
- Ownership
- Privately Held (backing)
Hanyin Life doesn't have a composite mark yet — a PA Mark is published once enough pricing inputs exist (trade prints, fund marks, round prices). The rest of the record below builds toward it.
Recorded secondary trades
No secondary trades in Hanyin Life shares have been recorded yet. When a print lands — third-party, direct report, or platform — it appears here with structure, source, and price.
Institutional fund marks
No SEC-registered fund has reported a fair-value mark on Hanyin Life in its N-PORT filings yet. We sweep new filings monthly.